Men Health

GLP-1 for Men: Results, Side Effects, and What's Different

GLP-1 Companion · 8 min read

GLP-1 receptor agonists — medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have transformed the treatment of obesity and type 2 diabetes. Most large clinical trials enroll roughly equal numbers of men and women, but the results are not identical between the sexes. For men specifically, there are meaningful differences in how quickly weight comes off, how body composition changes, and what downstream health benefits emerge. If you are a man considering or currently taking a GLP-1 medication, understanding these differences can help you set realistic expectations and get the most out of treatment.

Do Men Lose Weight Faster on GLP-1s?

The short answer is: somewhat. Subgroup analyses from the landmark STEP 1 trial (semaglutide 2.4mg for obesity) found that men lost approximately 16% of body weight over 68 weeks, compared to about 14.5% in women. On a percentage basis, men tend to lose weight slightly faster and reach their nadir weight a bit earlier.

However, the picture is more nuanced when you look at who reaches the highest weight-loss milestones. Women are actually more likely to achieve 20% or greater total body weight loss on semaglutide. The likely explanation is that women on average have a higher percentage of body fat at baseline, meaning the medication's fat-mobilizing effects have more substrate to work with. Men tend to plateau at a lower percentage loss but reach that plateau more rapidly.

Body Composition: Why Men Look Different After Weight Loss

One reason men's weight loss on GLP-1s can feel less visually dramatic than expected — despite substantial scale changes — has to do with body composition. Men naturally carry higher amounts of skeletal muscle mass. Because skeletal muscle is denser and more metabolically active than fat, a 200-pound man who loses 30 pounds may look noticeably leaner but not dramatically different in overall physique compared to a woman losing the same proportion of weight.

The preservation of lean mass is actually a significant advantage for men. GLP-1 medications cause weight loss primarily through caloric restriction driven by appetite suppression. Like all calorie-restricted weight loss, some lean mass is typically lost alongside fat. Men's higher absolute muscle mass provides a buffer: proportionally, they tend to preserve more lean tissue during the weight loss process, which translates to sustained metabolic rate and functional strength.

Why Resistance Training Is Non-Negotiable for Men

Despite this relative advantage, muscle loss during GLP-1-driven weight loss is still a real concern for men, particularly those losing weight rapidly. Without deliberate resistance training, men can lose meaningful amounts of muscle alongside fat.

• Aim for at least 3 resistance training sessions per week, targeting all major muscle groups.
• Prioritize compound movements: squats, deadlifts, rows, presses, and pull-ups or lat pulldowns.
• Do not rely on cardiovascular exercise alone — cardio supports heart health and calorie expenditure but does not preserve muscle mass the way resistance training does.
• Track strength over time as a proxy for lean mass preservation; if your lifts are staying stable or improving, you are preserving muscle.
• Progressive overload — gradually increasing weight or resistance — is the key stimulus for muscle retention during weight loss.

Protein Needs Are Higher for Men on GLP-1s

Because GLP-1 medications significantly reduce appetite, many patients — men and women alike — struggle to eat enough protein. For men, this is especially important given their higher muscle mass and typically larger frame. General clinical guidance for GLP-1 users emphasizes at least 1.2 to 1.6 grams of protein per kilogram of body weight per day, but many sports medicine and obesity medicine physicians recommend higher targets for men who are active.

• A 200-pound (90 kg) man should target approximately 150 to 180 grams of protein per day during active weight loss.
• Distribute protein intake across 3 to 5 meals or snacks rather than concentrating it in one or two sittings.
• Prioritize high-quality complete proteins: chicken, fish, eggs, Greek yogurt, cottage cheese, lean beef, and legumes.
• Protein shakes and powders can help fill gaps when appetite suppression makes eating large protein-dense meals difficult.
• Adequate leucine intake (found in whey, eggs, and meat) specifically stimulates muscle protein synthesis.

Testosterone and GLP-1: A Meaningful Connection

One of the most significant and underappreciated benefits of GLP-1-driven weight loss for men is the impact on testosterone levels. Obesity is strongly associated with low testosterone, and the mechanism is well understood: adipose (fat) tissue expresses an enzyme called aromatase, which converts testosterone into estradiol (a form of estrogen). The more fat tissue a man carries, the more aromatase activity he has, and the more testosterone is converted to estrogen. The result is a vicious cycle: low testosterone promotes fat storage, and more fat lowers testosterone further.

Research consistently shows that significant weight loss — regardless of the method — raises testosterone levels by 30 to 50%. GLP-1-specific data is also emerging: a 2024 retrospective analysis of 847 men on semaglutide found a mean increase of 127 ng/dL in total testosterone after 12 months, with the magnitude of increase correlating strongly with the amount of weight lost (r = 0.68). For context, many men with obesity-related low testosterone start in the 200 to 300 ng/dL range; a 127 ng/dL increase can move them from symptomatic hypogonadism into the normal range.

Erectile Dysfunction: Surprising Benefits

Multiple lines of evidence now connect GLP-1 therapy to improvements in erectile function. A 2024 retrospective cohort study found that men on GLP-1 medications had a 31% lower rate of new erectile dysfunction (ED) diagnoses compared to matched controls who did not take GLP-1 medications, over 24 months of follow-up. This reduction exceeded what weight loss alone would be expected to produce, suggesting possible direct vascular effects of GLP-1 receptor activation in penile tissue.

The mechanisms are multi-layered: rising testosterone from fat loss, improved endothelial function in blood vessels, reduced systemic inflammation, better sleep (including improvement of sleep apnea, which is itself a significant cause of ED), and psychological improvements from successful weight loss all contribute. Men who have struggled with ED in the context of obesity should be aware that improvement in sexual function is a realistic and evidence-supported expectation with GLP-1 therapy.

Side Effects in Men: What to Watch For

The side effect profile of GLP-1 medications is similar across sexes — nausea, constipation, reflux, and reduced appetite are the most commonly reported — but there is an important behavioral difference: men are significantly less likely to report side effects to their healthcare providers. Cultural norms around stoicism and not complaining about physical symptoms mean that men may silently tolerate nausea or gastrointestinal discomfort rather than asking for adjustments.

• Nausea is most common at the start of each new dose level and typically improves within 1 to 2 weeks.
• Eating smaller meals, avoiding high-fat or high-sugar foods, and staying upright after eating all reduce nausea.
• Constipation is common and preventable: increase fiber, stay well hydrated, and consider a fiber supplement.
• Fatigue during dose escalation is real; plan higher-intensity workouts around your best-energy days.
• Muscle cramps can occur with rapid weight loss — ensure adequate potassium, magnesium, and sodium intake.

Dosing: Men Often Benefit From Maximum Tolerated Dose

Clinical data suggests that men, on average, are more likely to reach and tolerate maximum approved doses of GLP-1 medications compared to women. Most men are titrated to the full maintenance dose — 2.4 mg weekly semaglutide (Wegovy) or 15 mg weekly tirzepatide (Zepbound) — and benefit substantially from doing so. The dose-response relationship in GLP-1 therapy is real: higher doses produce greater appetite suppression and greater weight loss in most patients.

This does not mean rushing to the highest dose; the titration schedule exists precisely to allow the body to adapt and minimize side effects. But men who are tolerating a given dose well should work with their provider to continue escalating toward the maximum tolerated dose rather than staying at a comfortable but subtherapeutic level.

Addressing the Stigma: Taking a "Diet Drug"

A meaningful barrier to GLP-1 treatment for men is social stigma. Despite significant cultural shifts in how obesity is understood — it is a complex, chronic, and largely biological disease, not a character flaw — many men still internalize the message that needing medication for weight management represents a personal failure. This stigma is not grounded in science, but it is real and it stops men from seeking treatment that could meaningfully extend and improve their lives.

No one questions a man for taking a statin to lower his cholesterol or metformin to manage his blood sugar. GLP-1 medications work on a biological system — the hormonal signaling pathway that regulates hunger and metabolism — that functions differently in people with obesity. Using them is not cheating; it is medicine.

Research consistently shows that obesity-related conditions — cardiovascular disease, type 2 diabetes, sleep apnea, joint disease, and cancer — disproportionately shorten men's lives and compress their healthy years. GLP-1 therapy is one of the most powerful tools we have to address these conditions, and men who access it do not owe anyone an explanation.

Key Takeaways for Men on GLP-1 Therapy

1. Men lose weight slightly faster on GLP-1s but may need to manage expectations about the visual transformation, given higher baseline muscle mass.
2. Resistance training 3 times per week and high protein intake (150-180g/day for most men) are essential to preserving muscle during weight loss.
3. Testosterone levels typically increase 30-50% with significant weight loss, with measurable benefits for energy, mood, libido, and body composition.
4. Erectile dysfunction frequently improves with GLP-1 therapy through multiple mechanisms beyond weight loss alone.
5. Report GI side effects to your provider — adjustments are available and keeping silent often leads to unnecessary discontinuation.
6. Work toward the maximum tolerated dose; men tend to achieve the best results at full therapeutic doses.
7. Taking medication for obesity is not weakness — it is evidence-based treatment for a biological condition.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Lincoff et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity. NEJM.